Background and Purpose-Phosphoinositide 3-kinase (PI3K)-␥ is linked to inflammation and oxidative stress. This study was conducted to investigate the role of the PI3K␥ in the blood-brain barrier dysfunction and brain damage induced by focal cerebral ischemia/reperfusion. Methods-Wild-type and PI3K␥ knockout mice were subjected to middle cerebral artery occlusion (60 minutes) followed by reperfusion. Evans blue leakage, brain edema, infarct volumes, and neurological deficits were examined. Oxidative stress, neutrophil infiltration, and matrix metallopeptidase-9 were assessed. Activation of nuclear factor-B and expression of proinflammatory and pro-oxidative genes were studied. Results-PI3K␥ deficiency significantly reduced blood-brain barrier permeability and brain edema formation, which were time-dependently correlated with preventing the degradation of the tight junction protein, claudin-5, and the basal lamina protein, collagen IV, and the phosphorylation of myosin light chain in brain microvessels. PI3K␥ deficiency suppressed ischemia/reperfusion-induced nuclear factor-B p65 (Ser536) phosphorylation and the expression of the pro-oxidant enzyme NADPH oxidase (Nox1, Nox2, and Nox4) and proinflammatory adhesion molecules (E-and P-selectin, intercellular adhesion molecule-1) at different time points. These molecular changes were associated with significant inhibition of oxidative stress (superoxide production and malondialdehyde content), neutrophil infiltration, and matrix metallopeptidase-9 expression/activity in PI3K␥ knockout mice. Eventually, PI3K␥ deficiency significantly reduced infarct volumes and neurological scores at 24 hours after ischemia/reperfusion. Conclusions-Our results provide the first direct demonstration that PI3K␥ plays a significant role in ischemia/ reperfusion-induced blood-brain barrier disruption and brain damage. Future studies need to explore PI3K␥ as a potential target for stroke therapy. Key Words: blood-brain barrier Ⅲ ischemic stroke Ⅲ metallopeptidases Ⅲ oxidative stress Ⅲ PI3 kinase-␥ E ffective stroke therapies require early restoration of cerebral blood flow to ischemic brain tissue. However, early reperfusion can cause blood-brain barrier (BBB) disruption, leading to cerebral edema, brain hemorrhage, and neuronal death. 1 These complications of early reperfusion, which result from excess production of reactive oxygen species (ROS) and overexpression/activation of metalloproteinases (MMPs), especially MMP-9, significantly limit the benefits of stroke therapies. 1,2 The BBB is primarily formed by specialized brain endothelial cells that are interconnected by well-developed tight junctions and provides a dynamic interface between the blood and the brain. 3 BBB disruption is a critical event in the pathogenesis of acute ischemic stroke; however, the molecular mechanisms involved are not completely understood. 4 Experimental evidence and clinical data suggest that ROS and MMP-9 disrupt the BBB by degrading the tight junctions (eg, claudins and occludin) and basal lamina proteins (eg, collagen IV, laminin, fibronectin). 4 -6 Although a plethora of drugs targeting ROS and MMP-9 are effective in the treatment of acute stroke in animal models, their translation into clinical practice has completely failed. 1,2 Thus, there is an urgent need to identify molecular signaling pathways that can be targeted with innovative therapies. 7 Phosphoinositide 3-kinases (PI3Ks) are a family of enzymes characterized by protein and lipid kinase activity. Although these kinases have been linked to Akt/PKB activation and neuroprotection during cerebral ischemia, 8 disappointedly, there is no direct and conclusive evidence of a causal link between the PI3Ks and the development of disease. Previous experimental studies that investigated the roles of PI3Ks in stroke are limited Received August 31, 2010; final revision received January 12, 2011; accepted January 18, 2011. From the Departments of Neurosurgery (J.R., S.Z., Y.S., N.A., L.G.) and Molecular and Cellular Physiology (D.N.G., L.G.) in number, and almost all of the studies used pan-PI3K inhibitors (eg, wortmannin, Ly294002). These pan-PI3K inhibitors also inhibit a number of other kinases such as MAP kinase, mTOR, and DNA-dependent protein kinases. 9 To date, the roles of specific PI3K isoforms in the disease process of stroke have never been investigated. Recent studies, using genetically modified mice and isoformselective PI3K inhibitors, have revealed that different PI3K isoforms often exert distinct cellular functions downstream of specific receptors in various cell types. 10 The class Ib PI3K (p11o␥), primarily expressed in leukocytes and also in endothelial cells, regulates different cellular functions relevant to inflammation, oxidative stress, and tissue damage. 10 -12 Increasing evidence reveals that PI3K␥ is critically involved in a number of inflammatory and autoimmune diseases. Genetic deletion and pharmacological inhibition of PI3K␥ have been shown to protect from atherosclerosis, myocardial ischemia/reperfusion injury, and rheumatoid arthritis in mice. [13] [14] [15] Currently, pharmacological targeting of PI3K␥ represents 1 of the most promising approaches for developing novel safe treatments for inflammatory diseases. 9, 10 Our recent study has shown that PI3K␥ is constitutively expressed in normal brain microvessels and significantly upregulated in postischemic brain primarily in activated microglia after cerebral ischemia in mice. 16 Genetic deletion of PI3K␥ not only inhibits neutrophil infiltration, but also blocks microglia activation and expansion in vivo. 16 This study was designed to investigate the role of PI3K␥ in BBB dysfunction and brain damage elicited by focal cerebral ischemia/reperfusion and explore potential mechanisms involved.
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Materials and Methods

Mice
C57BL/6J mice (wild-type [WT]) were purchased from Jackson Laboratories (Bar Harbor, ME). PI3K-p110␥ knockout (PI3K␥ KO) mice were kindly provided by Dr. P.J.M. (the Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria) and maintained at the LSU Health Sciences CenterShreveport (Shreveport, LA), and housed in a specific pathogen-free environment. Male mice (8 to 10 weeks old, 22 to 25 g) were used in this study. PI3K␥ KO mice (backcrossed onto a C57BL/6 background for Ͼ10 generations) exhibit normal size, weight, viability, fertility, blood cell count, and chemistries as described (Supplemental Table I ; http://stroke.ahajournals.org). 17 All animal protocols were approved by the Institutional Animal Care and Use Committee.
Middle Cerebral Artery Occlusion and Reperfusion
Focal cerebral ischemia was induced by transient occlusion of the left middle cerebral artery (tMCAO) with a 6-0 silicone-coated nylon monofilament (Doccol Corp) as previously described. 18 Subgroups of WT mice and PI3K␥ KO mice were randomly selected to receive MCAO or sham procedures. In ischemic groups, animals were subjected to 60 minutes tMCAO followed by reperfusion for indicated times. In the sham controls, the arteries were visualized but not disturbed. Rectal temperature was maintained at 37Ϯ0.5°C throughout the procedure from the start of the surgery until the animals recovered from anesthesia with a feedback-regulated heating pad. Systemic parameters including pH and blood gases were all within normal ranges and there were no differences between WT and KO mice. Regional cerebral blood flow was monitored by laser Doppler flowmetry (MSP300XP; ADInstruments Inc) as previously described. 19 Only animals that exhibited a reduction in cerebral blood flow Ͼ85% during MCAO and a cerebral blood flow recovery by Ͼ80% after 15 minutes of reperfusion were included in the study. The number of animals used for each experimental group are provided in the figure legends and summarized in the Supplemental Table II .
Determination of Evans Blue Leakage, Edema, and Water Content
Evans blue leakage was assessed as previously described. 20 Two percent Evans blue (Sigma-Aldrich, 6 mL/kg) in 0.9% saline was injected into the right femoral vein, and animals were euthanized 3 hours after the injection. Each hemisphere was homogenized in 2 mL of N,N-dimethylformamide (Sigma-Aldrich), incubated for 18 hours at 55°C, and centrifuged. The absorption of the supernatant was measured at 620 nm by spectrophotometry. Brain tissue water content was measured by the wet and dry weight method. 21 It was calculated asϭ100ϫ(wet weightϪdry weight)/wet weight. Edema volume was calculated asϭ[(ipsilateral hemisphere's volume/contralateral hemisphere's volume)Ϫ1]ϫ100. 21 
Infarct Volumes and Neurological Deficits
Mice were euthanized 24 hours after tMCAO, and the brains were removed and 2-mm-thick coronal sections were immersed in 2% 2,3,5-triphenyltetrazolium chloride (Sigma) at 37°C for 30 minutes. 18 The area of infarction in each slice was determined by a computerized image analysis system (National Institutes of Health Image), and the average infarct volume was calculated by multiplying the distance between sections. All measurements were performed by 2 blinded researchers and the mean of their results was calculated. The calculated infarct volumes were corrected for brain swelling as previously described. 21 Twenty-four hours after tMCAO, the modified Bederson score 22 was used to determine global neurological function according to the following scoring system: 0, no deficit; 1, forelimb flexion; 2, decreased resistance to lateral push; 3, unidirectional circling; 4, longitudinal spinning; and 5, no movement. Motor function and coordination were evaluated by the grip test. 23 For this test, the mouse was placed midway on a string between 2 supports and rated as follows: 0, falls off; 1, hangs onto string by 1 or both forepaws; 2, as for 1 and attempts to climb onto string; 3, hangs onto string by 1 or both forepaws plus 1 or both hindpaws; 4, hangs onto string by fore-and hindpaws plus tail wrapped around the string; and 5, escape (to the supports). Neurological scores were always assessed by a blinded independent investigator.
Immunohistochemistry
Immunostaining was performed as described previously. 24, 25 The primary antibodies were: goat anti-MMP-9 (1:500; R&D Systems), rabbit antimouse polymorphonuclear neutrophil antibody (1:500; Accurate Chemical) to label neutrophils, ionized calcium-binding adapter molecule 1 (1:1000; Wako) to label microglia, glial fibrillary acidic protein (1:500; Dako) to label astrocytes, neuronal nuclear antigen (1:1000; Millipore) to label neuronal cells, CD31 (1:100; BD Pharmingen) to label endothelial cells, rabbit anticlaudin-5 (1:200; Zymed), rabbit anticollagen IV (1:500; Abcam), and phosphomyosin light chain 2 (Ser19) mouse mAb (1:500; Cell Signaling). For double-labeling immunofluorescence, after primary antibody incubation, sections were incubated with Alexa fluorochromeconjugated secondary antibodies (1:1000 in phosphate-buffered saline; Invitrogen). At lease 5 animals were used per group per time point. The number of polymorphonuclear neutrophil-positive and MMP-9-positive cells was counted in predefined areas of the ischemic hemisphere at 5 coronal levels (rostrocaudal levels, ϩ1.6, ϩ1.0, ϩ0.4, Ϫ0.2, Ϫ0.8 mm from bregma). 24 Cell counts were performed by 2 blinded researchers under light microscopy (ϫ200) and the mean of their results was calculated and adjusted to express as mean cell number/mm 2 .
Determination of ROS Production
Mice were euthanized at 4 or 24 hours after tMCAO. ROS production in the brain was assessed using in vivo dihydroethidium (DHE) staining as previously described 25 with minor modifications. DHE, a cell-permeable oxidative-sensitive fluorescent dye, is oxidized to ethidium by superoxide but not by other ROS. 26, 27 Ethidium intercalates into DNA and emits a red fluorescence mainly from the nuclei. 26 DHE (Sigma-Aldrich) was prepared as a 1.0-mg/mL solution in 1% dimethyl sulfoxide. DHE solution (1.0 mg/kg) was injected into the femoral vein of anesthetized mice and allowed to circulate for 4 hours. Mice were euthanized and perfusion-fixed with 4% paraformaldehyde at 4 hours and 24 hours after reperfusion.
Cryostat sections (20 m thickness) were prepared and photographed with a Nikon fluorescent microscope with excitation at 510 to 550 nm and emission Ͼ580 nm to detect oxidized DHE. DHE fluorescence intensity was analyzed by 2 blinded researchers using Nikon NIS-Elements software (Basic Research 3.0) and the mean of their results was calculated. Fluorescence intensity was measured in predefined areas of the ischemic cortex and striatum at 5 coronal levels as described previously. The sum of the fluorescence intensity for each region was divided by the total number of pixels analyzed and expressed as fluorescence intensity relative to the level in contralateral controls. 27
Quantitative Real-Time Polymerase Chain Reaction
Mice were euthanized at multiple time points (1, 3, 6, 12, 24 , 72 hours) after tMCAO, and the brains were removed. Total RNA was extracted from the ipsilateral cortices (between coronal levels ϩ2 mm to Ϫ3 mm relative to bregma) by using the TRIzol extraction kit (Life Technologies). Samples from sham-operated animals served as basal controls. Expression levels of NADPH oxidase subunits (Nox1, Nox2, and Nox4) and adhesion molecules (E-selectin, P-selectin, intercellular adhesion molecule-1) were determined by quantitative real-time real-time polymerase chain reaction with a Bio-Rad thermocycler and an SYBR green kit (Bio-Rad) according to the recommendations of the manufacturer. Primer sequences are given in Supplemental Table III3 . All primers were purchased from Invitrogen. All samples were run in triplicate. Relative levels of mRNA were normalized to the mouse HPRT housekeeping gene and the results are expressed as fold changes versus the sham controls.
Western Blot
Mice were euthanized at indicated times after tMCAO. Brains were stored at Ϫ80°C until analysis. Western blot analysis was performed as described previously. 28 Briefly, whole-cell protein was prepared from the ischemic cortices (between coronal levels ϩ2 mm to Ϫ3 mm relative to bregma). Samples from sham-operated animals served as basal controls. Brain tissues were homogenized in 10ϫ vol of cold protein extraction buffer (complete tablet; Roche), centrifuged at 13 000 rpm for 20 minutes at 4°C, and the supernatant was used for analysis. After adding the 2ϫ volume of sample buffer (Invitrogen) to the supernatant, equal amounts were loaded per lane. Antibodies used were as follows: rabbit polyclonal antibodies to total nuclear factor-B p65 and phospho-p65 at serine 536 
Gelatin Zymography
MMP-9 or MMP-2 activity in brain homogenates was determined by gelatin zymography as previously described. 29 Briefly, brains were removed quickly and dissected on ice, and the ipsilateral and contralateral hemispheres (between coronal levels ϩ2 mm to Ϫ4 mm relative to bregma) were homogenized with lysis buffer (50 mmol/L Tris-HCl [pH 7.4], 150 mmol/L NaCl, 5 mmol/L CaCl2, 0.05% Brij-35, and 1% Triton X-100). Supernatants obtained from homogenized brain tissues were incubated with gelatin-Sepharose 4B (GE Healthcare). Equal amounts of protein (20 g) were loaded per lane and separated on 10% Tris-glycine gels with 0.1% gelatin as substrate. A mixture of MMP-9 and MMP-2 (CC073; Chemicon International) was used as a gelatinase standard. Images of the gels were scanned with a densitometer (GS-700; Bio-Rad Laboratories), and quantification was analyzed with Multi-Analyst 1.0 software (Bio-Rad Laboratories).
Enzyme-Linked Immunosorbent Assays
Enzyme-linked immunosorbent assays of brain cortice homogenates were performed to detect total MMP-9 protein using a Quantikine mouse MMP-9 (total) immunoassay kit (R&D Systems), myeloperoxidase using the mouse Enzyme-linked immunosorbent assay kit (HK210; Hycult Biotechnology), and malondialdehyde (MDA) using the NWLSS MDA assay kit (Northwest Life Science Specialties, LLC) according to the instructions by the manufacturers. MDA is 1 of the end products of lipid peroxidation and a commonly used marker of oxidant stress. All samples were run in triplicate.
Statistical Analysis
Data were expressed as meanϮSD. Statistical analysis was performed using analysis of variance and Student t test. Differences with PϽ0.05 were considered statistically significant.
Results
PI3K␥ Deficiency Reduces Evans Blue Leakage and Brain Edema
In WT mice, Evans blue leakage was markedly increased within the first 4 hours of reperfusion followed by an obvious decrease before 24 hours of reperfusion (data not shown), and a second rise was observed between 24 and 72 hours (maximally at 48 hours; Figure 1A ). These findings are consistent with the time course described in a rat stroke model 30 and suggest that there is a biphasic opening of the BBB after ischemia/reperfusion in our mouse model. Evans blue leakage was largely reduced in PI3K␥ KO mice ( Figure  1A ). Brain water content and brain swelling were significantly reduced in KO mice compared with WT mice ( Figure  1B ). There were no significant differences between WT and KO mice with respect to vascular anatomy (Supplemental Figure I ) and cerebral blood flow (Supplemental Figure II ) and systemic parameters (Supplemental Table I ).
PI3K␥ Deficiency Reduces Brain Infarction and Neurological Deficits
Twenty-four hours after tMCAO, the infarct volume that developed in PI3K␥ KO mice was significantly smaller than in WT mice (23.5Ϯ7.2 mm 3 versus 52.8Ϯ9.3 mm 3 , PϽ0.05; Figure 1C ). The reduction in infarct size was functionally relevant, because the Bederson score assessing global neurological function and the grip test score assessing motor function were significantly better in PI3K␥ KO mice than in WT mice at 24 hours after tMCAO ( Figure 1D ).
PI3K␥ Deficiency Reduces the Damage to BBB Structural Components
Immunostaining was performed to demonstrate ischemia/ reperfusion-induced time-dependent changes in the tight junction protein, claudin-5, and the basal lamina protein, collagen IV, because both proteins are critical for maintaining BBB integrity. 3, 4 For claudin-5 staining, in WT mice, claudin-5 levels in the ischemic cortical regions were markedly decreased at 4 hours followed by partial recovery at 24 hours and then reduced more markedly at 48 hours after reperfusion ( Figure 2A ). In KO mice, the damage to claudin-5 was profoundly attenuated at all these time points (Figure 2A ). Double immunostaining with anticlaudin-5 and anti-CD31 antibodies showed strong colocalization in the nonischemic (contralateral) hemisphere, indicating the endothelial origin of the claudin-5 in microvessels (Supplemental Figure IIIA) . For collagen IV staining, a similar pattern in the extensive and dense networks of the collagen IV was noted in the WT and KO nonischemic (contralateral) hemisphere ( Figure 2B ). In WT mice, collagen IV levels were decreased slightly at 4 hours but decreased obviously at 24 and 48 hours after reperfusion ( Figure 2B ). In KO mice, the damage to collagen IV was profoundly prevented at all these time points ( Figure 2B ). These findings were confirmed by Western blotting analysis of claudin-5 and collagen IV in brain homogenates (Supplemental Figure IV) . 
PI3K␥ Deficiency Reduces Microvascular Endothelial Myosin Light Chain Phosphorylation
The phosphorylation of the myosin light chain (MLC) in brain microvessels has been linked to the acute (4 hours) damage of the tight junction protein claudin-5 after cerebral ischemia/ reperfusion. 25 In the nonischemic (contralateral) hemisphere, the phosphorylation of the MLC (Ser19) in microvessels was minimal ( Figure 2C) , consistent with the previous data. 25 In WT mice, ischemia/reperfusion induced a marked phosphorylation of the MLC (Ser19) in the ischemic cortex at 4 hours, but the MLC phosphorylation levels were largely decreased at 24 hours and thereafter ( Figure 2C ). In KO mice, the ischemia/ reperfusion-induced MLC phosphorylation in microvessels was markedly inhibited ( Figure 2C ). This finding was confirmed by Western blotting analysis of the phosphor-MLC (Ser19) in brain homogenates ( Figure 2D ). Double immunostaining with anti-MLC (Ser19) and anti-CD31 antibodies showed strong colocalization in the ischemic cortex of WT mice at 4 hours, indicating the endothelial origin of the phosphorylated MLC in microvessels (Supplemental Figure IIIB) .
PI3K␥ Deficiency Attenuates Nuclear Factor-B Activation and Inflammatory Gene Expression
Transcription factor nuclear factor-B (NF-B) is known to be activated in cerebral ischemia. 31 We used PI3K␥-deficient mice to determine whether PI3K␥ is required for the activation of NF-B elicited by tMCAO ( Figure 3A) . Western blot analysis showed that the phosphorylation of NF-B p65 (ser536) was dramatically induced at 4 hours and more prominently at 24 hours after tMCAO in WT mice; this result is consistent with previous findings. 28 In PI3K␥ KO mice, the phosphorylation of NF-B p65 (ser536) was profoundly attenuated.
NF-B plays a critical role in regulating the expression of many different genes involved in oxidative stress and proinflammatory response. 31 Next, we examined the effect of PI3K␥ deficiency on mRNA expression of the NADPH oxidase subunits (Nox1, Nox2, Nox4) at multiple time points after tMCAO ( Figure 3B ). In WT mice, the expression of Nox-1 and Nox-2 was elevated significantly within early hours (1 to 6 hours) and continued to increase or maintain high level up to 72 hours after tMCAO; this result is consistent with previous findings. 24, 32, 33 However, a significant increase of Nox-4 mRNA expression was detected at relatively late time points (12 to 72 hours); this result is consistent with a recent study. 34 In PI3K␥ KO mice, the expression of Nox-1, Nox-2, and Nox-4 was significantly attenuated ( Figure 3B ).
Leukocyte adhesion and transmigration across the BBB is regulated by multiple proinflammatory adhesion molecules, including selectins and intercellular adhesion molecule-1. Thus, we examined the effect of PI3K␥ deficiency on the expression of proinflammatory adhesion molecules (E-selectin, P-selectin, intercellular adhesion molecule-1; Figure 3C ). In WT mice, ischemia/reperfusion induced a significant increase in the expression of E-selectin and P-selectin observed from 3 to 24 hours (peak at 12 hours), whereas an intercellular adhesion molecule-1 increase was observed from 3 to 72 hours (peak at 24 hours). In PI3K␥ KO mice, the expression of these adhesion molecules was significantly attenuated ( Figure 3C ).
PI3K␥ Deficiency Attenuates ROS Production and Oxidative Stress
Using the superoxide-sensitive dye DHE staining technique, we assessed the effect of PI3K␥ deficiency on ROS production after tMCAO. In WT mice, the ROS signal in the ischemic cortex and striatum was markedly increased at 4 and 24 hours (greatest at 4 hours) after reperfusion ( Figure 4A-B) ; this result is consistent with previous findings. 27 In PI3K␥ KO mice, ROS production was profoundly attenuated at both time points (Figure 4A-B) .
MDA is an end product of lipid peroxidation and an indicator of oxidative stress. In WT ischemic hemispheres, the MDA levels did not altered during the first 4 hours compared with sham controls but were significantly increased 24 hours after reperfusion ( Figure 4C) ; this result is consistent with a previous study. 33 In KO mice, MDA levels in postischemic hemispheres were not significantly increased after ischemia/reperfusion ( Figure 4C ).
PI3K␥ Deficiency Reduces Neutrophil Infiltration and Neutrophil-Associated MMP-9
The cellular sources of MMP-9 in the postischemic brain include mainly infiltrated neutrophils (PMNs) but also cerebral microvascular endothelial cells after acute ischemic stroke in animals and humans. 5, 6, 25 Immunostaining showed that PMNs and MMP-9 were not detected either in the contralateral hemisphere or in the sham-operated mice (Figure 5A-B) . In WT mice, only a few PMNs and MMP-9-positive (MMP-9ϩ) cells were noted in the ischemic hemisphere at 4 hours (not shown), but the number of positively stained cells was markedly increased between 24 and 72 hours after tMCAO ( Figure 5A-B) . In PI3K␥ KO mice, the number of PMNs and MMP-9ϩ cells in the ischemic hemisphere was largely reduced (Figure 5A-B) . It is worth noting that PMNs and MMP-9ϩ cells exhibited similar immunostaining patterns at different time points. Moreover, enzymelinked immunosorbent assay of myeloperoxidase, a marker of neutrophil infiltration, confirmed that neutrophil infiltration was inhibited in PI3K␥ KO mice compared with WT controls ( Figure 5C ). Using double immunostaining, we determined the cellular sources of MMP-9 in the postischemic brain. Our data showed strong colocalization of MMP-9 signal with the neutrophil-specific marker (PMN), but not with neuronal (neuronal nuclei), microglial/macrophage (ionized calcium-binding adapter molecule 1), or astrocytic (glial fibrillary acidic protein) markers ( Figure 5D ), indicating that infiltrated neutrophils were the major cellular source of MMP-9 in our model. Moreover, we examined the endothelial expression of MMP-9 after tMCAO. In the WT and KO contralateral (nonischemic) hemisphere, endothelial MMP-9 was not detected. In WT mice, the immunoreactivity for MMP-9 in the endothelium of microvessels in the ischemic hemisphere was minimal at 4 hours but markedly increased at 24 hours, declined to a low level at 48 hours, and disappeared at 72 hours after tMCAO (Supplemental Figure V) . MMP-9ϩ neutrophils were shown abundantly around microvessels (ie, perivascular MMP-9) at 72 hours in the WT ischemic hemisphere (Supplemental Figure V) . In KO mice, the expression of MMP-9 in the endothelium of microvessels was minimal at all these time points (Supplemental Figure V) .
PI3K␥ Deficiency Reduces MMP-9 Activity and Protein Content
Using gelatin zymography, we assessed the effect of PI3K␥ deficiency on MMP activation at 24 hours after reperfusion. Two clear bands could be detected for MMP-9 corresponding to pro-MMP-9 at 92 kDa and cleaved form at 82 kDa (Figure 6A). Total MMP-9 levels (including pro-MMP-9 and cleaved form) and cleaved MMP-9 were significantly increased in homogenates of the ischemic hemispheres in WT mice, but this increase was largely inhibited in KO mice ( Figure  6A-B) . In contrast, no significant change for MMP-2 (63 kDa) was noted ( Figure 6A-B) , consistent with the previous findings in rat. 35 Consistent with these findings, enzyme-linked immunosorbent assay showed that total MMP-9 protein content was increased in homogenates of the WT ischemic hemispheres at 24 hours, but this increase was largely attenuated in PI3K␥ KO mice ( Figure 6C ).
Discussion
The present study provides the first direct demonstration that PI3K␥ plays a central role in ischemia/reperfusion-induced BBB disruption and brain damage. Among the Class I PI3Ks, PI3K␥ is a key regulator of inflammatory and oxidative responses and has been implicated in a number of inflammatory diseases such as atherosclerosis and myocardial ischemia/reperfusion injury. However, the role of PI3K␥ in the pathogenesis of stroke has not been investigated. Here, we demonstrate for the first time that genetic deletion of PI3K␥ prevented the BBB disruption and offered protection against brain damage in acute ischemic stroke. We identify PI3K␥ as a crucial player of cerebral inflammation and oxidative stress, possibly through modulating NF-B activation, proinflammatory gene expression, neutrophil infiltration, and MMP-9 expression/activation in the postischemic brain.
In this study, we demonstrated that absence of PI3K␥ provided a profound protection against the damage to BBB structural integrity, eventually attenuating BBB dysfunction and brain damage elicited by focal cerebral ischemia/reperfusion. We observed that ischemia/reperfusion caused a biphasic opening of the BBB corresponding to the early (4 hours) and late (48 hours) increase in BBB permeability. This observation is consistent with the time course of the BBB opening previously described in a rat stroke model. 30, 36 Despite extensive investigation, the molecular mechanisms underlying the ischemia/reperfusion-induced biphasic BBB opening have not been well defined. Among various components of the BBB, the tight junction protein, claudin-5, and the basal lamina protein, collagen IV, are 2 of the most widely studied components of the BBB; both are critical for maintaining the BBB structural integrity and permeability. [2] [3] [4] The degradation of the cerebrovascular claudin-5 as well as the basal lamina collagen IV has been highly correlated with the dynamic process of BBB disruption after cerebral ischemia. 25, 35, 37, 38 The results of this study suggest that the early BBB opening correlated with an acute disruption of the tight junction protein, claudin-5, and also with an acute phosphorylation of the MLC in brain microvessels, whereas the late BBB opening correlated with a sustained disruption of claudin-5 and a marked loss of the basal lamina protein, collagen IV. Thus, PI3K␥ signaling is important for maintaining the structural integrity of the BBB in acute stroke.
Oxidative stress is probably 1 of the most important mechanisms involved in BBB disruption and neuronal death in acute ischemic stroke. 39 PI3K␥ is known to play an essential role in ROS production in peripheral tissues and many cell types, including leukocytes and endothelial cells through activation of NADPH oxidase. 40, 41 However, in vivo the exact role of PI3K␥ in ROS production in the brain under physiological and pathophysiological conditions is unknown. The findings of the present study indicate that PI3K␥ is a critical regulator of oxidative stress in the postischemic brain after cerebral ischemia/reperfusion. Consistent with the study by Cho et al, 27 we observed that ROS production was induced in the ischemic cortex and striatum most robustly at 4 hours but was relatively low at 24 hours after reperfusion in WT mice, whereas ROS production was markedly inhibited in PI3K␥ KO mice. It is unlikely that the attenuation of ROS production observed in PI3K␥ KO mice is a consequence rather than a cause of the reduced brain damage, because in rodent models of cerebral ischemia, the tissue damage is not fully developed at the time that ROS production was greatest (0 to 4 hours). 42 There is ample evidence that NF-B is activated in cerebral ischemia and promotes ischemic brain injury through regulating expression of many different genes involved in oxidative stress and inflammation. 28, 31, 43, 44 Among the 5 NF-B subunits, p65/RelA and p50 are known to be responsible for a detrimental effect in cerebral ischemia, and the phosphorylation of NF-B p65 (Ser536) is required for activation and nuclear translocation of NF-B. 31 Consistent with previous studies, 28, 43, 44 the present data showed that the phosphorylation of NF-B p65 (Ser536) was robustly induced in the postischemic brain at 4 and 24 hours after cerebral ischemia/ reperfusion in WT mice, whereas the induction of p65 phosphorylation was markedly inhibited in PI3K␥ KO mice. Moreover, the results of the present study showed that ischemia/reperfusion-induced upregulation of NADPH oxidase subunits (Nox1, Nox2, and Nox4) was largely inhibited in PI3K␥ KO mice at all time points (1 to 72 hours) after tMCAO. In this regard, we assume that regulation of NF-B and NADPH oxidase may represent a possible mechanism whereby PI3K␥ promotes oxidative stress elicited by focal cerebral ischemia. Our findings may have potential implications for preventing ROS production at its source by blocking PI3K␥ signaling upstream of NADPH oxidase.
Although NADPH oxidase has been regarded as a major source of ROS in ischemic stroke, 39 there is no conclusive evidence of a causal link between specific NADPH oxidase subunits and the development of disease. Contradictory results have been reported in the literature. [32] [33] [34] Experimental data reported by Kahles et al 32 and Chen et al 33 consistently showed that genetic deletion of Nox2 prevented early BBB dysfunction and reduced infarct size in mice 24 hours after tMCAO. Intriguingly, Kleinschnitz et al 34 showed that genetic deletion of Nox4 profoundly reduced oxidative stress, BBB dysfunction, and neuronal apoptosis 24 hours after tMCAO, whereas deficiency of Nox1 or Nox2 had no impact on infarct size or functional outcome. Importantly, Kleinschnitz et al investigated the roles of Nox1, Nox2, and Nox4 under identical experimental conditions. The exact reasons for this discrepancy are unclear at present. 34 There is ample evidence, in human and animal stroke models, that increased expression and activation of MMP-9 play a critical role in the BBB disruption (particularly in late BBB opening) after ischemic stroke. 2, 5, 6, 35 Clinical and experimental data have shown that increased MMP-9 in postischemic brain tissue is mainly a result of infiltrated leukocytes (particularly neutrophils) during acute ischemic stroke. 6, 25, 45 Consistent with previous studies, the present data indicate that infiltrated neutrophils are the major source of MMP-9 in the ischemic hemisphere during the 24-to 72-hour period after reperfusion in WT mice. In addition to infiltrated neutrophils, cerebral endothelial cells are considered as another important source of local MMP-9 in ischemic stroke. 2, 5, 6 In this study, we observed that ischemia/ reperfusion-induced MMP-9 expression in brain microvessels was minimally at 4 hours and prominent at 24 hours, declined at 48 hours, and disappeared at 72 hours after tMCAO.
NF-B is known to regulate expression of many different proinflammatory genes. 31 Absence of PI3K␥ blocked ischemia/reperfusion-induced neutrophil adhesion and infiltration into postischemic brain, and this effect could be explained by our findings that ischemia/reperfusion-induced expression of the adhesion molecules (E-and P-selectin, intercellular adhesion molecule-1) was markedly inhibited in PI3K␥ KO mice. In vivo, PI3K␥ deficiency inhibited ischemia/ reperfusion-induced neutrophil adhesion and infiltration in the postischemic brain. In vitro, PI3K␥ deficiency blocked tumor necrosis factor-␣-induced intercellular adhesion molecule-1 expression and neutrophil firm adhesion in cultured mouse brain microvascular endothelial cells (Supplemental Figure VI) .
Collectively, our findings reveal the molecular mechanisms by which blocking PI3K␥ inhibited neutrophil adhesion and infiltration and eventually reduced both neutrophiland endothelial cell-associated MMP-9 in postischemic brain after tMCAO.
Study Limitation
There are several potential limitations to this study. First, although we demonstrated that PI3K␥ deficiency reduced ROS production possibly through NADPH oxidase-mediated mechanism, we cannot be sure which NADPH oxidase subunits and what mechanisms are exactly involved. Second, the precise cellular actions of PI3K␥ in stroke, especially regarding the contribution of the endothelial and microglial PI3K␥ to the development of ischemic stroke, need to be defined by future studies. Third, it is now apparent that no single animal model can precisely replicate human ischemic stroke; future studies in other stroke models (eg, thromboembolic stroke model with or without tissue plasminogen activator treatment) are warranted.
Conclusions
We have demonstrated that genetic deletion of PI3K␥ prevents ischemia/reperfusion-associated BBB disruption and attenuates tissue damage in acute experimental stroke. These results have identified PI3K␥ as a crucial player in the pathophysiology of acute ischemic stroke. Future studies will be needed to identify the precise cellular actions of PI3K␥ in stroke and explore PI3K␥ as a potential target for stroke therapy.
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Supplemental Methods and Data
I. Supplemental Methods
Cerebrovascular anatomy
The circle of Willis and its branches were examined as previously described (Lambertsen, et al. 2009 ). PI3Kγ knockout (KO) and C57Bl6 wildtype (WT) were overdosed with pentobarbital and perfused with 10 ml of 0.9% saline, followed by 10 ml of a 50% solution of Quink carbon black ink Fig. 1 ). Most mice also had fully formed PCOM arteries; similar PCOM artery scores were obtained in WT and KO mice. These findings indicated that the reduced infarct volume observed in KO mice was not caused by differences in vascular anatomy between WT and KO mice.
Regional cerebral blood flow measurement
Regional cerebral blood flow (CBF) was monitored by laser Doppler flowmetry (MSP300XP; ADInstruments Inc). Probes were placed at the center (from bregma: 3.5 mm lateral, 1.5 mm caudal) and periphery (from bregma: 1.5 mm lateral, 1.5 mm caudal) of the ischemic territory as previously described ). After transient ischemia, CBF was restored by withdrawal of the nylon suture. Only animals that exhibited a reduction in CBF>85% during MCAO and a CBF recovery by >80% after 15 min of reperfusion were included in the study.
Western blot
Mice were killed at indicated times after tMCAO (n = 4-5 for per group per time point). Brains were stored at -80 o C until analysis. Western blot analysis was performed as described previously ). Briefly, whole-cell protein was prepared from the ischemic cortices (between coronal levels +2 mm to −3 mm relative to bregma). Samples from sham-operated animals served as basal controls. Brain tissues were homogenized in 10× vol of cold protein extraction buffer (complete tablet; Roche), centrifuged at 13,000 rpm for 20 min at 4 °C, and the supernatant was used for analysis. After adding the 2× volume of sample buffer (Invitrogen) to the supernatant, equal amounts were loaded per lane. Antibodies used were as follows: rabbit anti-claudin-5
(1:500; Zymed Laboratories), goat anti-occludin (1:1000; Santa Cruz), and goat anti-collagen IV 
Cell Cultures
Primary mouse brain microvascular endothelial cells (BMECs) were prepared using the method as previously described (Song, et al. 2003; Wu, et al. 2003) . Briefly, brain microvessels were harvested from the cerebral cortex of 6-8-week-old male wild-type mice (n=20) and PI3Kγ KO (n=20) mice, and BMECs were purified with anti-murine CD31 precoated M-450 Dynabeads (Dynal). Then cells were plated onto tissue culture dishes pre-coated with collagen I and cultured in complete growth medium (DMEM/F-12 containing 10% fetal bovine serum (FBS), 10% horse serum, 0.1 mg/ml endothelial cell growth supplement, 0.1 mg/ml heparin, and 100 units/ml penicillin/streptomycin). The purity of BMECs was identified by the presence of factor VIII and von Willebrand factor was >95% of the cell population. All experiments were performed on confluent quiescent cells in primary cultures (passage 3-5) that were exposed overnight to 0.1%FBS/DMEM.
Neutrophil Firm Adhesion to Endothelial Cells
Neutrophil firm adhesion to endothelial cells was performed as previously described (Bhunia, et al. 1998 ; Li et al. 2008 ). BMECs, isolated from WT and PI3Kγ KO mice, were grown to confluence in 96-well gelatin-coated plates. Polymorphonuclear leukocytes (PMNs, or neutrophils) were isolated from peritoneal lavage of WT mice as previously described (Li et al. 2008 ). PMN purity was >95%, and the viability assessed by trypan blue exclusion was >98%. PMNs (1. Only male mice (8-10 weeks old) were used in this study. The number of animals used for each experimental group are also provided in the figure legends.
